僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Vunakizumab （Anti-Human IL17A Recombinant Antibody） is a recombinant human IgGκ monoclonal antibody that targets IL-17A and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis and inflammatory arthritis